Showing results (181-190 of 297) with videos related to
Sort By:
Pageof 30
Cancer|July 13, 2021
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclaxKunhwa Kim, Abhishek Maiti, Sanam Loghavi, et al.Cancer|May 29, 2024
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantationJayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, et al.The American Journal of Surgical Pathology|March 2, 2017
Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy SpecimensRose Lou Marie C Agbay, Carlos A Torres-Cabala, Keyur P Patel, et al.Blood Advances|December 4, 2024
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapyWei-Ying Jen, Koji Sasaki, Farhad Ravandi, et al.Journal of Hematology & Oncology|May 2, 2023
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemiaHagop Kantarjian, Fadi G Haddad, Nitin Jain, et al.Haematologica|October 2, 2025
Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitorNicholas J Short, Sanam Loghavi, Musa Yilmaz, et al.The American Journal of Surgical Pathology|July 2, 2019
Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell NeoplasmNarittee Sukswai, Phyu P Aung, C Cameron Yin, et al.Nature Communications|March 19, 2024
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2021
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 casesHong Fang, Mariko Yabe, Xiaohui Zhang, et al.Haematologica|September 2, 2018
Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemiaChi Young Ok, Sanam Loghavi, Dawen Sui, et al.Pageof 30